Rachel A. Gibson

7.6k total citations
51 papers, 2.2k citations indexed

About

Rachel A. Gibson is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Rachel A. Gibson has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Neurology and 10 papers in Genetics. Recurrent topics in Rachel A. Gibson's work include DNA Repair Mechanisms (12 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and CRISPR and Genetic Engineering (5 papers). Rachel A. Gibson is often cited by papers focused on DNA Repair Mechanisms (12 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and CRISPR and Genetic Engineering (5 papers). Rachel A. Gibson collaborates with scholars based in United Kingdom, United States and Netherlands. Rachel A. Gibson's co-authors include Christopher G. Mathew, Hans Joenje, Paul M. Matthews, Neil V. Morgan, Éliane Gluckman, Fayçal Hentati, Manuel Buchwald, Matthew J. Farrer, Jorge R. Oksenberg and Petra Jakobs and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and PLoS ONE.

In The Last Decade

Rachel A. Gibson

49 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel A. Gibson United Kingdom 24 1.2k 557 382 310 236 51 2.2k
Annie Laquerrière France 32 1.4k 1.1× 584 1.0× 248 0.6× 842 2.7× 235 1.0× 109 3.3k
D. Goossens Belgium 25 797 0.6× 548 1.0× 299 0.8× 455 1.5× 54 0.2× 75 1.9k
Hasan O. Akman United States 29 1.3k 1.1× 596 1.1× 169 0.4× 424 1.4× 181 0.8× 71 2.5k
Mar Matarín United Kingdom 20 712 0.6× 517 0.9× 425 1.1× 258 0.8× 156 0.7× 26 1.8k
A. Gélot France 26 1.1k 0.9× 385 0.7× 210 0.5× 384 1.2× 86 0.4× 77 2.7k
Rossella Tupler Italy 26 1.7k 1.4× 561 1.0× 74 0.2× 365 1.2× 90 0.4× 78 2.4k
Jharna Ray India 21 1.3k 1.1× 623 1.1× 193 0.5× 172 0.6× 49 0.2× 86 2.2k
Brad T. Tinkle United States 15 585 0.5× 1.1k 1.9× 145 0.4× 419 1.4× 116 0.5× 16 2.3k
Alessandra Baumer Switzerland 27 1.7k 1.4× 1.3k 2.2× 66 0.2× 286 0.9× 93 0.4× 88 2.9k
Gabriele Stumm Germany 15 631 0.5× 145 0.3× 401 1.0× 257 0.8× 88 0.4× 23 1.6k

Countries citing papers authored by Rachel A. Gibson

Since Specialization
Citations

This map shows the geographic impact of Rachel A. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel A. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel A. Gibson more than expected).

Fields of papers citing papers by Rachel A. Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel A. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel A. Gibson. The network helps show where Rachel A. Gibson may publish in the future.

Co-authorship network of co-authors of Rachel A. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel A. Gibson. A scholar is included among the top collaborators of Rachel A. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel A. Gibson. Rachel A. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Raman, Isabelle Borghini-Fuhrer, Gonzalo J. Domingo, et al.. (2024). Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria. Malaria Journal. 23(1). 145–145.
2.
Oliver, Victoria, Sarah Siederer, Anthony Cahn, et al.. (2023). Exploring the role of ex vivo metabolism on blood and plasma measurements of oxytocin among women in the third stage of labour: A post hoc study. British Journal of Clinical Pharmacology. 89(12). 3669–3680. 3 indexed citations
3.
Gajewska‐Knapik, Katarzyna, Kirsten R. Palmer, Anthony Cahn, et al.. (2023). Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open‐label study. British Journal of Clinical Pharmacology. 89(12). 3681–3689. 5 indexed citations
4.
Clarke, Andrew, et al.. (2022). Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care. BMJ Paediatrics Open. 6(1). e001467–e001467. 3 indexed citations
5.
6.
Moore, Fhionna R., et al.. (2018). The gender suicide paradox under gender role reversal during industrialisation. PLoS ONE. 13(8). e0202487–e0202487. 14 indexed citations
7.
Bush, William S., Jacob L. McCauley, Philip L. DeJager, et al.. (2011). A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Genes and Immunity. 12(5). 335–340. 23 indexed citations
8.
Dächsel, Justus C., Kenya Nishioka, Carles Vilariño‐Güell, et al.. (2010). Heterodimerization of Lrrk1–Lrrk2: Implications for LRRK2-associated Parkinson disease. Mechanisms of Ageing and Development. 131(3). 210–214. 19 indexed citations
9.
Jasińska‐Myga, Barbara, Jennifer M. Kachergus, Carles Vilariño‐Güell, et al.. (2010). Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa. Movement Disorders. 25(13). 2052–2058. 14 indexed citations
10.
Nishioka, Kenya, Carles Vilariño‐Güell, Stephanie A. Cobb, et al.. (2009). Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa. Neuroscience Letters. 477(2). 57–60. 22 indexed citations
11.
Nishioka, Kenya, M. Kéfi, Christian Wider, et al.. (2009). A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. 81(4). 391–395. 32 indexed citations
12.
Hulihan, Mary, Jennifer M. Kachergus, Ruchi Upmanyu, et al.. (2008). PINK1 mutations and parkinsonism. Neurology. 71(12). 896–902. 41 indexed citations
13.
Lea, Rod A., Dale R. Nyholt, Claire Bellis, et al.. (2005). A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics. 6(2). 67–72. 36 indexed citations
14.
Waisfisz, Quinten, Neil V. Morgan, Michelangelo Savino, et al.. (1999). Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nature Genetics. 22(4). 379–383. 153 indexed citations
15.
16.
Cox, P., Rachel A. Gibson, Neil V. Morgan, & Louise Brueton. (1997). VACTERL with hydrocephalus in twins due to Fanconi anemia (FA): Mutation in the FAC gene. American Journal of Medical Genetics. 68(1). 86–90. 34 indexed citations
17.
Richardson, Deborah, et al.. (1996). Fanconi's anaemia presenting as acute myeloid leukaemia in adulthood. British Journal of Haematology. 94(1). 126–128. 8 indexed citations
18.
Pronk, Jan C., Rachel A. Gibson, Anna Savoia, et al.. (1995). Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nature Genetics. 11(3). 338–340. 78 indexed citations
19.
Gibson, Rachel A., et al.. (1993). EcoRI RFLP in the Fanconi anaemia complementation group C gene (FACC). Human Molecular Genetics. 2(9). 1509–1509. 2 indexed citations
20.
Gibson, Rachel A., Manuel Buchwald, Roland G. Roberts, & Christopher G. Mathew. (1993). Characterisation of the exon structure of the Fanconi anaemia group C gene by vectorette PCR. Human Molecular Genetics. 2(1). 35–38. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annie Laquerrière Breakdown of academic impact, for papers by D. Goossens Breakdown of academic impact, for papers by Hasan O. Akman Breakdown of academic impact, for papers by Mar Matarín Breakdown of academic impact, for papers by A. Gélot Breakdown of academic impact, for papers by Rossella Tupler Breakdown of academic impact, for papers by Jharna Ray Breakdown of academic impact, for papers by Brad T. Tinkle Breakdown of academic impact, for papers by Alessandra Baumer Breakdown of academic impact, for papers by Gabriele Stumm
Rankless by CCL
2026